Trinity Biotech reported $103.29M in Assets for its fiscal quarter ending in December of 2024.


Assets Change Date
Abbott USD 84B 2.55B Jun/2025
Bayer EUR 105.24B 3.95B Jun/2025
Bio-Rad Laboratories USD 10.21B 687.2M Jun/2025
EDAP TMS EUR 86.06M 7.02M Dec/2024
J&J USD 193.67B 13.57B Mar/2025
Roche Holding CHF 101.8B 6.02B Dec/2024
Siemens EUR 162.46B 138M Jun/2025
Thermo Fisher Scientific USD 101.23B 2.19B Jun/2025
Tosoh JPY 1.31T 17.48B Jun/2025
Trinity Biotech USD 103.29M 5.84M Dec/2024
Veracyte USD 1.34B 28.69M Jun/2025